Urinary Soluble HLA Class I Antigen in Patients with Minimal Change Disease: A Predictor of Steroid Response

Publisher： Karger

E-ISSN： 2235-3186|79|1|44-49

ISSN： 1660-8151

Source： Nephron, Vol.79, Iss.1, 1998-04, pp. : 44-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful Treatment of Steroid-Resistant Minimal Change Disease with Mycophenolate Mofetil

By  

American Journal of Nephrology, Vol. 22, Iss. 5-6, 2002-10 ,pp. : 569-572

Karger

Access to resources Recommend Favorite

Novel Trial for the Treatment of Steroid Dependency in Minimal Change Disease: Combined Therapy of Camostat Mesilate and Glycyrrhizin

By  

Nephron, Vol. 90, Iss. 3, 2002-02 ,pp. : 357-360

Karger

Access to resources Recommend Favorite

Glomerular Hypertrophy Is a Risk Factor for Relapse in Minimal Change Disease Patients

By  

Nephron, Vol. 132, Iss. 1, 2016-0 ,pp. : 43-50

Karger

Access to resources Recommend Favorite

A Unique Cause of Proteinuria in Pregnancy: Class II Lupus Nephritis with Concomitant Minimal Change Disease

By  

Case Reports in Nephrology and Dialysis, Vol. 6, Iss. 3, 2016-09 ,pp. : 101-105

Karger

Access to resources Recommend Favorite

Simultaneous Improvement of Minimal-Change Nephrotic Syndrome and Anemia with Steroid Therapy

By  

Nephron, Vol. 81, Iss. 1, 1999-01 ,pp. : 84-88

Karger

Access to resources Recommend Favorite